Literature DB >> 26109726

Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.

Tomonari Shigemura1, Masaaki Shiohara1, Masayoshi Kato2, Shuichi Furuta2, Kazuko Kaneda3, Kazuhiro Morishita3, Hiroo Hasegawa4, Masahiro Fujii5, Agnes Gorlach6, Kenichi Koike1, Tohru Kamata7.   

Abstract

UNLABELLED: Human T-cell leukemia virus type 1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and transforms T cells in vitro. To our knowledge, the functional role of reactive oxygen species (ROS)-generating NADPH oxidase 5 (Nox5) in HTLV-1 transformation remains undefined. Here, we found that Nox5α expression was upregulated in 88% of 17 ATL patient samples but not in normal peripheral blood T cells. Upregulation of the Nox5α variant was transcriptionally sustained by the constitutive Janus family tyrosine kinase (Jak)-STAT5 signaling pathway in interleukin-2 (IL-2)-independent HTLV-1-transformed cell lines, including MT1 and MT2, whereas it was transiently induced by the IL-2-triggered Jak-STAT5 axis in uninfected T cells. A Nox inhibitor, diphenylene iodonium, and antioxidants such as N-acetyl cysteine blocked proliferation of MT1 and MT2 cells. Ablation of Nox5α by small interfering RNAs abrogated ROS production, inhibited cellular activities, including proliferation, migration, and survival, and suppressed tumorigenicity in immunodeficient NOG mice. The findings suggest that Nox5α is a key molecule for redox-signal-mediated maintenance of the HTLV-1 transformation phenotype and could be a potential molecular target for therapeutic intervention in cancer development. IMPORTANCE: HTLV-1 is the first human oncogenic retrovirus shown to be associated with ATL. Despite the extensive study over the years, the mechanism underlying HTLV-1-induced cell transformation is not fully understood. In this study, we addressed the expression and function of ROS-generating Nox family genes in HTLV-1-transformed cells. Our report provides the first evidence that the upregulated expression of Nox5α is associated with the pathological state of ATL peripheral blood mononuclear cells and that Nox5α is an integral component of the Jak-STAT5 signaling pathway in HTLV-1-transformed T cells. Nox5α-derived ROS are critically involved in the regulation of cellular activities, including proliferation, migration, survival, and tumorigenicity, in HTLV-1-transformed cells. These results indicate that Nox5α-derived ROS are functionally required for maintenance of the HTLV-1 transformation phenotype. The finding provides new insight into the redox-dependent mechanism of HTLV-1 transformation and raises an intriguing possibility that Nox5α serves as a potential molecular target to treat HTLV-1-related leukemia.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26109726      PMCID: PMC4524067          DOI: 10.1128/JVI.00983-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Deregulation of cell-signaling pathways in HTLV-1 infection.

Authors:  William W Hall; Masahiro Fujii
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 2.  Activation of NF-kappaB by HTLV-I and implications for cell transformation.

Authors:  Shao-Cong Sun; Shoji Yamaoka
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.

Authors:  N Mori; M Fujii; S Ikeda; Y Yamada; M Tomonaga; D W Ballard; N Yamamoto
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

4.  Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia.

Authors:  Aura S Kamiguti; Lena Serrander; Ke Lin; Robert J Harris; John C Cawley; David J Allsup; Joseph R Slupsky; Karl-Heinz Krause; Mirko Zuzel
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.

Authors:  K Shuai; J Halpern; J ten Hoeve; X Rao; C L Sawyers
Journal:  Oncogene       Date:  1996-07-18       Impact factor: 9.867

6.  Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.

Authors:  S C Sun; S B Maggirwar; E W Harhaj; M Uhlik
Journal:  Oncogene       Date:  1999-02-18       Impact factor: 9.867

7.  Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells.

Authors:  T Mochizuki; S Furuta; J Mitsushita; W H Shang; M Ito; Y Yokoo; M Yamaura; S Ishizone; J Nakayama; A Konagai; K Hirose; K Kiyosawa; T Kamata
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

8.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

Authors:  J X Lin; T S Migone; M Tsang; M Friedmann; J A Weatherbee; L Zhou; A Yamauchi; E T Bloom; J Mietz; S John
Journal:  Immunity       Date:  1995-04       Impact factor: 31.745

9.  Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

Authors:  T S Migone; J X Lin; A Cereseto; J C Mulloy; J J O'Shea; G Franchini; W J Leonard
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

10.  Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Authors:  Mariko Tomita; Hirochika Kawakami; Jun-Nosuke Uchihara; Taeko Okudaira; Masato Masuda; Takehiro Matsuda; Yuetsu Tanaka; Kazuiku Ohshiro; Naoki Mori
Journal:  Retrovirology       Date:  2006-04-09       Impact factor: 4.602

View more
  11 in total

1.  Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke.

Authors:  Ana I Casas; Pamela Wm Kleikers; Eva Geuss; Friederike Langhauser; Thure Adler; Dirk H Busch; Valerie Gailus-Durner; Martin Hrabê de Angelis; Javier Egea; Manuela G Lopez; Christoph Kleinschnitz; Harald Hhw Schmidt
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

2.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

Review 3.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

4.  A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder.

Authors:  Sara Poletti; Martina Riberto; Benedetta Vai; Davide Ghiglino; Cristina Lorenzi; Alice Vitali; Silvia Brioschi; Clara Locatelli; Alessandro Serretti; Cristina Colombo; Francesco Benedetti
Journal:  J Mol Neurosci       Date:  2018-08-02       Impact factor: 3.444

Review 5.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

Review 6.  Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.

Authors:  Rodrigo Prieto-Bermejo; Marta Romo-González; Alejandro Pérez-Fernández; Carla Ijurko; Ángel Hernández-Hernández
Journal:  J Exp Clin Cancer Res       Date:  2018-06-26

Review 7.  Regulation of HTLV-1 transformation.

Authors:  Kyle J Ernzen; Amanda R Panfil
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

Review 8.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

9.  NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors.

Authors:  Smitha Antony; Guojian Jiang; Yongzhong Wu; Jennifer L Meitzler; Hala R Makhlouf; Diana C Haines; Donna Butcher; Dave S Hoon; Jiuping Ji; Yiping Zhang; Agnes Juhasz; Jiamo Lu; Han Liu; Iris Dahan; Mariam Konate; Krishnendu K Roy; James H Doroshow
Journal:  Mol Carcinog       Date:  2017-08-30       Impact factor: 4.784

10.  Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.

Authors:  Shariful Islam; Claudia M Espitia; Daniel O Persky; Jennifer S Carew; Steffan T Nawrocki
Journal:  Viruses       Date:  2021-07-20       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.